Evidence map›Paper›PMID 24621280›Full record

ArticleBMC immunology2014

T-cell activation discriminates subclasses of symptomatic primary humoral immunodeficiency diseases in adults.

Marie-Quitterie Picat, Rodolphe Thiébaut, François Lifermann, Xavier Delbrel, Daniel Adoue, Linda Wittkop, Anne-Laure Fauchais, Patrick Rispal, Jean-François Moreau, Jean-François Viallard

Open access · goldAbstract read
In one paragraph

Article in BMC immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 10 institutions in 1 country.

Marie-Quitterie Picat
Rodolphe ThiébautINSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux F-33076, France. rodolphe.thiebaut@isped.u-bordeaux2.fr.
François Lifermann
Xavier Delbrel
Daniel Adoue
Linda Wittkop
Anne-Laure Fauchais
Patrick Rispal
Jean-François Moreau
Jean-François Viallard
Bordeaux Population Health · FRCentre de Recherche Inria Bordeaux - Sud-Ouest · FRCentre Hospitalier Agen - Nérac · FRCentre Hospitalier de Dax –Côte d’Argent · FRCentre Hospitalier De Pau · FRHôpital Cardiologique du Haut-Lévêque · FRHôpital Dupuytren · FRHôpital Purpan · FRInserm · FRInstitut national de recherche en informatique et en automatique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSymptomatic Primary Humoral Immunodeficiency Diseases (PHID) constitute a highly heterogeneous group of diseases characterized by a shared hypogammaglobulinemia, resulting in increased risk of recurrent or severe infections. Associations have been described with a variety of immunological abnormalities involving B and T-cell differentiation, T-cell activation and innate immunity. However, PHID discrimination remains based on B-lymphocyte abnormalities and other components of the immune system have not been sufficiently taken into account. We carried out unsupervised and supervised methods for classification in a cohort of 81 symptomatic PHID patients to evaluate the relative importance of 23 immunological parameters and to select relevant markers that may be useful for diagnosis and prognosis.

resultsWe identified five groups of patients, among which the percentage of PHID complications varied substantially. Combining the set of markers involved in PHID supported the existence of two distinct mechanisms associated with complications. Switched memory B-cell attrition and CD8+ HLA-DR + activated T-cell increase were the prominent abnormalities observed in PHID complications. Furthermore, in a subgroup of 57 patients with common variable immunodeficiency, the classification that added CD8+ HLA-DR + to the consensual EUROclass classification was better than the EUROclass model in predicting complications.

conclusionThese results highlight the importance of T-cell activation that may improve discrimination of PHID patients in specific subgroups and help to identify patients with different clinical outcomes.

Indexed as

AdultBiomarkersB-LymphocytesCluster AnalysisCross-Sectional StudiesFemaleHumansImmunity, InnateImmunoglobulin IsotypesImmunologic Deficiency SyndromesKiller Cells, NaturalLymphocyte ActivationMaleMiddle AgedReceptors, Antigen, T-Cell, gamma-deltaSensitivity and SpecificityBiomarkersImmunoglobulin IsotypesReceptors, Antigen, T-Cell, gamma-delta

Identifiers

PMID24621280
PMCPMC4008268
OpenAlexW2074174198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.